Strategies for Persistent Agitated Delirium in Palliative Care (R01)

Overview:

• Team: Principal Investigator: David Hui, M.D., Associate Professor, M. D. Anderson Cancer Center; co-investigator, Sandra K. Hanneman, PhD, RN, FAAN
• Funded by National Cancer Institute
• Overview: This clinical trial studies the effects of pharmacological interventions and dosages to reduce agitated delirium-related distress and alleviate end-of-life suffering. Dr. Hanneman leads a team using biomarker assessment of inflammatory cytokine responses to the study’s various treatment arms.